FDA removes a major barrier to Real-World Evidence: implications for medical device and IVD regulation
The U.S. Food and Drug Administration has announced a significant policy shift that removes one of the key barriers to the use of real-world evidence...
Adrianna
Pyrzanowska
Regulatory Affairs Associate